President and CEO of Cantel Medical Corp. (CMN, Financial) Andrew A Krakauer sells 11,505 shares of CMN on 04/09/2010 at an average price of $19.59 a share.
Cantel Medical Corp. has a market cap of $328.2 million; its shares were traded at around $19.51 with a P/E ratio of 16.7 and P/S ratio of 1.3. The dividend yield of Cantel Medical Corp. stocks is 0.5%. Cantel Medical Corp. had an annual average earning growth of 9.1% over the past 10 years.
CMN is in the portfolios of Jim Simons of Renaissance Technologies LLC, Chuck Royce of Royce& Associates.
Cantel Medical Corp. has a market cap of $328.2 million; its shares were traded at around $19.51 with a P/E ratio of 16.7 and P/S ratio of 1.3. The dividend yield of Cantel Medical Corp. stocks is 0.5%. Cantel Medical Corp. had an annual average earning growth of 9.1% over the past 10 years.
CMN is in the portfolios of Jim Simons of Renaissance Technologies LLC, Chuck Royce of Royce& Associates.
Directors and Officers Recent Trades:
- Buy:: Chairman, 10% Owner Charles M Diker bought 5,000 shares of CMN stock on 10/23/2009 at the average price of 16.16, the price of the stock has increased by 20.73% since.
- Sell:: Senior VP and General Counsel Eric W Nodiff sold 4,000 shares of CMN stock on 02/03/2010 at the average price of 19.13, the price of the stock has increased by 1.99% since.
- Sell:: Executive Vice President Seth R Segel sold 4,000 shares of CMN stock on 02/03/2010 at the average price of 19.06, the price of the stock has increased by 2.36% since.
- Sell:: Director Robert L Barbanell sold 5,250 shares of CMN stock on 01/05/2010 at the average price of 20.46, the price of the stock has decreased by 4.64% since.
- Sell:: Officer of Subsidiary Roy K Malkin sold 11,000 shares of CMN stock on 01/05/2010 at the average price of 20.84, the price of the stock has decreased by 6.38% since.
